Pfizer announces a new, expanded indication for IBRANCE® (palbociclib)
REVLIMID® (lenalidomide) Receives Approval for use as Maintenance Therapy for MM Patients After auto-HSCT
KEYTRUDA Approved for Refractory or Relapsed classical Hodgkin Lymphoma (cHL)
BMS Receeves FDA Approval for Opdivo in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma
CMS assigns permanent Healthcare Common Procedure Coding System (HCPCS) code specific to IMLYGIC®
Follow RMOS on Twitter
What's New @ RMOS:
AstraZeneca's TAGRISSO® (osimertinib) Receives FDA Full Approval
View the RMOS 2016 Year in Review!
ACCC Submits Comments to CMS on Part B Drug Proposal
ACCCBuzz Blog: ACCC Voices Part B Demo Concerns on Capitol Hill & at CMS
FDA Approves Gilotrif for Patients with Squamous Cell Carcinoma of the Lung
| ACCC Resources
| ASCO Resources
| ASCO Connection |
© Oncology State Society Network. All rights reserved.